MSH2 and cancer: In a large genotype‐phenotype correlation study, mutations in MLH1 and MSH2 were highly prevalent in patients with a positive family history and cancer diagnosis at young age, whereas the prevalence of mutations in MSH6 and other genes were increased among isolated cancer cases and families with a higher age of cancer onset 43.